• LAST PRICE
    0.4750
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.4760/ 1
  • Ask / Lots
    0.5180/ 1
  • Open / Previous Close
    0.0000 / 0.4750
  • Day Range
    ---
  • 52 Week Range
    Low 0.4750
    High 21.1888
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.5104
TimeVolumePLXP
09:32 ET6090.5244
09:36 ET10000.5
09:39 ET3000.5
09:54 ET27880.53
09:57 ET1000.528
10:03 ET4250.5161
10:08 ET2000.5121
10:15 ET3000.5121
10:28 ET13310.52
10:32 ET1000.5122
10:35 ET1000.52
10:37 ET10210.5124
10:42 ET1000.5123
10:44 ET1000.52
10:48 ET6550.5123
10:50 ET1000.5123
10:53 ET2000.5125
11:09 ET10740.5127
11:11 ET2000.5128
11:15 ET18000.5199
11:18 ET1000.5128
11:20 ET1000.513
11:22 ET30000.513
11:24 ET26010.5131
11:26 ET7470.513
11:27 ET1000.513
11:29 ET9740.5131
11:31 ET10000.51305
11:33 ET4000.513
11:36 ET11000.5131
11:38 ET2000.51305
11:40 ET7000.51305
11:44 ET1000.513
11:45 ET1000.513
11:47 ET8000.513
11:49 ET22000.5125
11:51 ET23910.5058
11:54 ET1000.499
11:56 ET14000.4945
11:58 ET1000.4944
12:00 ET2000.4944
12:03 ET1000.4945
12:05 ET15150.4972
12:07 ET2000.4972
12:09 ET1000.4944
12:12 ET1000.4944
12:14 ET1000.5
12:16 ET2000.4944
12:18 ET2000.5
12:21 ET4000.4944
12:23 ET2000.498
12:25 ET6000.4939
12:30 ET22000.4939
12:34 ET1000.4939
12:38 ET1000.4939
12:39 ET1000.499
12:45 ET1000.4939
12:48 ET1000.4939
12:52 ET1000.4939
12:56 ET10240.494
12:57 ET2000.4968
12:59 ET1000.4939
01:01 ET29540.5
01:03 ET6720.5
01:08 ET1000.5
01:10 ET1000.5
01:15 ET1000.5
01:21 ET1000.5
01:26 ET2000.513
01:28 ET1000.513
01:30 ET2000.5
01:33 ET7590.5
01:37 ET1000.5
01:39 ET1000.5
01:46 ET1000.513
01:48 ET1000.5
01:51 ET1000.513
01:53 ET2200.512899
01:57 ET1000.513
02:04 ET1000.513
02:06 ET1000.5
02:08 ET15000.5123
02:09 ET1000.513
02:11 ET1000.5
02:15 ET1000.513
02:18 ET1000.5
02:20 ET1000.513
02:26 ET1000.513
02:27 ET1000.5
02:29 ET1910.5
02:31 ET2000.513
02:33 ET116920.513
02:36 ET1000.5
02:38 ET2000.5
02:40 ET7200.51
02:42 ET3000.5055
02:44 ET1000.5
02:45 ET2000.5
02:47 ET20000.5
02:49 ET2000.5
02:51 ET1000.5
02:54 ET60500.4954
02:56 ET44190.4939
02:58 ET4000.4969
03:00 ET2000.4939
03:02 ET6000.4939
03:03 ET20250.495
03:05 ET8000.5
03:07 ET16930.4939
03:09 ET1000.4939
03:12 ET2000.4954
03:14 ET6000.4969
03:16 ET2000.4979
03:18 ET3000.4958
03:20 ET26000.4968
03:21 ET2000.4958
03:23 ET14000.4959
03:25 ET18000.4958
03:27 ET11000.494
03:32 ET7170.49
03:34 ET22000.49
03:36 ET37500.485
03:38 ET12840.49
03:39 ET20000.49
03:52 ET1000.49
03:57 ET164620.49
03:59 ET507630.475
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPLXP
PLx Pharma Inc
14.4M
-0.3x
---
United StatesEVFM
Evofem Biosciences Inc
15.1M
0.0x
---
United StatesCALA
Calithera Biosciences Inc
14.3M
-0.1x
---
United StatesGHSI
Guardion Health Sciences Inc
8.7M
-0.2x
---
United StatesCPHI
China Pharma Holdings Inc
6.6M
-1.9x
---
United StatesKALA
Kala Pharmaceuticals Inc
16.7M
-0.1x
---
As of 2022-09-28

Company Information

PLx Pharma Inc. is a commercial-stage drug delivery platform technology company, which is focused on its clinically validated and patent-protected PLxGuard technology. The Company has two commercialized products, VAZALORE 81 milligram (mg) and VAZALORE 325 mg, which are liquid-filled aspirin capsules for over the counter (OTC) distribution. The Company markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage. PLxGuard drug delivery platform employs a pH-dependent release mechanism that relies on association of lipidic excipients with APIs for targeted release in the GI tract.

Contact Information

Headquarters
9 Fishers Ln Ste ESPARTA, NJ, United States 07871-2402
Phone
713-842-1249
Fax
713-842-3052

Executives

Executive Chairman of the Board
Michael Valentino
President, Chief Executive Officer, Director
Natasha Giordano
Chief Financial Officer, Head of Manufacturing and Supply Chain
Rita O Connor
Vice President - Trade Sales
Steven Valentino
Vice President - Investor Relations and Corporate Communications
Janet Barth

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$14.4M
Revenue (TTM)
$10.8M
Shares Outstanding
28.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
4.04
EPS
$-1.49
Book Value
$1.88
P/E Ratio
-0.3x
Price/Sales (TTM)
1.3
Price/Cash Flow (TTM)
---
Operating Margin
-588.90%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.